PLRXPliant Therapeutics, Inc.

$85M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$622,000

Operating Income

-$61M

Net Income

-$56M

EPS (Diluted)

$-0.92

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$45M

Free Cash Flow

-$47M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$484M

Total Liabilities

$91M

Stockholders' Equity

$393M

Cash & Equivalents

$80M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$248,000	-100.0%
Gross Profit	-$622,000	-$856,000	+27.3%
Operating Income	-$61M	-$47M	-28.1%
Net Income	-$56M	-$41M	-35.6%

PLRX Q2 2024 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena